Adopting the Results of Everest II Into Practice: A Clearer View From a Higher Level Study.
Publication
, Journal Article
Browning, DJ
Published in: JAMA Ophthalmol
November 1, 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA Ophthalmol
DOI
EISSN
2168-6173
Publication Date
November 1, 2017
Volume
135
Issue
11
Start / End Page
1214 / 1215
Location
United States
Related Subject Headings
- Verteporfin
- Ranibizumab
- Photochemotherapy
- Oxygen
- Ophthalmology & Optometry
- 1113 Opthalmology and Optometry
Citation
APA
Chicago
ICMJE
MLA
NLM
Browning, D. J. (2017). Adopting the Results of Everest II Into Practice: A Clearer View From a Higher Level Study. JAMA Ophthalmol, 135(11), 1214–1215. https://doi.org/10.1001/jamaophthalmol.2017.3118
Browning, David J. “Adopting the Results of Everest II Into Practice: A Clearer View From a Higher Level Study.” JAMA Ophthalmol 135, no. 11 (November 1, 2017): 1214–15. https://doi.org/10.1001/jamaophthalmol.2017.3118.
Browning DJ. Adopting the Results of Everest II Into Practice: A Clearer View From a Higher Level Study. JAMA Ophthalmol. 2017 Nov 1;135(11):1214–5.
Browning, David J. “Adopting the Results of Everest II Into Practice: A Clearer View From a Higher Level Study.” JAMA Ophthalmol, vol. 135, no. 11, Nov. 2017, pp. 1214–15. Pubmed, doi:10.1001/jamaophthalmol.2017.3118.
Browning DJ. Adopting the Results of Everest II Into Practice: A Clearer View From a Higher Level Study. JAMA Ophthalmol. 2017 Nov 1;135(11):1214–1215.
Published In
JAMA Ophthalmol
DOI
EISSN
2168-6173
Publication Date
November 1, 2017
Volume
135
Issue
11
Start / End Page
1214 / 1215
Location
United States
Related Subject Headings
- Verteporfin
- Ranibizumab
- Photochemotherapy
- Oxygen
- Ophthalmology & Optometry
- 1113 Opthalmology and Optometry